A. I.2 / A. I.3 / A. I.5 / A. I.4 / A. I.6 / A. I. / /
Organization
U.S. Department of Health and Human Services / Food and Drug Administration Center for Drug Evaluation and Research / Food and Drug Administration / office of Communications / U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research / CDER’s office of New Drugs / Center for Biologics Evaluation and Research / Center for Biologics Evaluation and Research Food and Drug Administration / Drug Information Center for Drug Evaluation / CDER’s office of Medical Policy / /
Biosimilars: Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009 Guidance for Industry